Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176351 | SCV000334499 | uncertain significance | not provided | 2015-08-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000457092 | SCV000542262 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-05-09 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852842 | SCV000995573 | likely benign | Primary dilated cardiomyopathy | 2019-05-08 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000176351 | SCV003823016 | uncertain significance | not provided | 2023-05-29 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004700538 | SCV005203604 | uncertain significance | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.45886A>G (p.Thr15296Ala) results in a non-conservative amino acid change located in the A-band region of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 3.5e-05 in 202674 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.45886A>G in individuals affected with TTN-related conditions and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 195716). Based on the evidence outlined above, the variant was classified as uncertain significance. |